As the monthly member magazine of the American Academy of Ophthalmology, EyeNet combines the wide reach and authority of the Academy with quick and useful information that Academy members can immediately apply in patient care. With EyeNet Magazine at the center of your marketing plan, you are guaranteed a loyal and avid reader base. Build out from that core with EyeNet’s satellite offerings: AAO 2017 print and electronic publications, custom supplements offered throughout the year, and digital opportunities to engage your audience when and how they choose to read the magazine.
EyeNet tops the charts in both peer-reviewed and non-peer-reviewed publications. Among all ophthalmologists, EyeNet ranks:
- #1 in ad page exposures for the 3rd year in a row! Your ad has a higher chance of being seen in EyeNet than any other ophthalmic publication. EyeNet is at 38%—the next publication is at 28%.
- #1 in high readers for the 8th year in a row! EyeNet has the most dedicated readers—those who read with high frequency in high numbers.
- #1 in average page exposures for the 5th year in a row! More ophthalmologists will view any given page in EyeNet than in competing publications.
Source: Kantar Media 2016 Eyecare Readership Study, Tables 701 and 801.
Contact Kelly Miller or Mark Mrvica of M.J. Mrvica Associates at email@example.com or 856-768-9360.
Space and Material Deadlines
Ad Close: December 5
Materials Close: December 9
Ad Close: January 4
Materials Close: January 6
Ad Close: January 30
Materials Close: February 3
Ad Close: March 6
Materials Close: March 10
Ad Close: April 3
Materials Close: April 7
Ad Close: May 1
Materials Close: May 5
Ad Close: May 29
Materials Close: June 2
Ad Close: July 3
Materials Close: July 7
Ad Close: August 1
Materials Close: August 4
Ad Close: September 4
Materials Close: September 8
Ad Close: October 2
Materials Close: October 6
Ad Close: November 1
Materials Close: November 3
||15" x 10"
||16 1/2" x 11 1⁄8"
||7" x 10"
||8 3⁄8" x 11 1⁄8"
|1/2 page (horiz)
||7" x 4 3/4"
||8 3⁄8" x 5 1/2"
|1/2 page (vert)
||3 1/4" x 10"
||4 1/4" x 11 1⁄8"
|2/3 page (vert)
||4 1/2" x 10"
||5 3⁄8" x 11 1⁄8"
||3 1/4" x 4 3/4"
EyeNet Trim Size (Page): 8 1/8" x 10 7/8"
EyeNet Trim Size (Spread): 16 1/4" x 10 7/8"
Live Matter: Bleed sizes include 1/8" trim from outside, bottom, top, and gutter. Keep live matter 1/2" from trim size of page.
Digital Ad Requirements
High-resolution PDF is the preferred file format. These flattened files (PDF/X-1a:2001) should be created using Adobe Acrobat Distiller 4.05 (or greater) or exported from Quark XPress or InDesign using the PDF/X-1a:2001 setting. All graphics and fonts must be embedded. Spot colors, RGB, and LAB colors should be converted to CMYK before creating the PDF. All trim and registration marks must appear outside the bleed area (1/8 inch from trim). Scanned images must be saved as high resolution (at least 266 dpi) in TIFF or EPS format. Maximum ink density should not exceed 300%.
TIFF and EPS files created with Illustrator or Photoshop are also acceptable. Supply both printer and screen fonts, including fonts embedded in art files. If submitting an InDesign document (CS4 or greater), you must supply all fonts and art files. Line art should be scanned at 600 dpi. Images (TIFF or EPS) should be at least 266 dpi and saved in CMYK mode.
Send the following:
- Ad file (high-resolution PDF or native files).
- Any supporting graphics that are incorporated in the ad (e.g., logo file, images).
- Screen and printer fonts. Fonts must still be included even if the ad is saved as an EPS file.
Ads can also be submitted via FTP. Materials should be placed within a folder titled with the company name and issue date. Email firstname.lastname@example.org when the ad is uploaded.
Server Address: ftp.aao.org
Password: provided by email@example.com
|Black and White
Cover and Other Special Rates
Cover 2: 35% over earned black-and-white rate.
Cover 3: 20% over earned black-and-white rate.
Cover 4: 50% over earned black-and-white rate.
Table of contents: 15% over earned black-and white rate.
Opposite editorial board: 10% over earned black and-white rate.
2-page insert: Two times earned black-and white rate.
4-page insert: Four times earned black-and white rate.
Advertising continuity program: Advertise in three issues and earn a free ad of equal size in the third issue.
15% allowed to agencies of record, with billing to the agency. In-house agencies are acceptable.
2017 Editorial Calendar
Personalized Medicine: Now that the genomics revolution is here, how is it playing out in eye care? EyeNet looks at several ophthalmic conditions ripe for precision diagnostics and therapeutics.
Distributed at APAO and Cataract Surgery: Telling It Like It Is!
Spotlight on Cataract: Revisiting the excitement from the Spotlight on Cataract session during AAO 2016, EyeNet presents a variety of surgical cases, along with audience poll questions and answers, and fresh expert commentary.
Corneal Cross-Linking: With its approval for use in the United States, corneal crosslinking is taking its place in clinical practice. A look at questions surrounding implementation, reimbursement, and malpractice. Plus, alternative techniques and devices that are up and coming.
Office-Based Cataract Surgery: There have been rumblings from Washington, D.C., that Medicare may consider allowing—or requiring—cataract surgery to be performed in an office setting. The pros and cons of such an arrangement.
Distributed at ASCRS
Tropical Diseases: Between the high-profile spread of Zika and the presence of chikungunya and vectors for dengue in the United States, tropical diseases are moving into previously unaffected areas. What to watch for.
Distributed at SOE
New Reimbursement: The Medicare Access and CHIP Reauthorization Act (MACRA) has ramifications both broad and deep. What you need to know to navigate these new reimbursement waters. And how the Academy IRIS Registry can help.
Expensive Drugs: When some anti-VEGF drugs cost nearly $2,000 per injection, practices must carefully manage costs. Experts discuss the practical and ethical issues of balancing financial concerns with optimal patient care.
Distributed at PAAO and ASRS
Biologics in Ophthalmology: Long a mainstay of therapy for systemic autoimmune conditions, biologic agents are finding new applications in diseases such as uveitis. A look at how they work, how to use them, and what to expect in terms of outcomes.
Online Dispensaries: Eyeglass vendors are going online, and refraction sites are popping up on the Web. Is this a disruptive innovation, or is it bad health care? What does this mean for your practice’s optical shop? And for you and your patients?
Distributed at ESCRS
Attention to Adherence: Adherence to medication, especially glaucoma drops, has been an intransigent problem for many patients and their ophthalmologists. How emerging technologies, novel drug delivery systems—and even new bottle caps—are providing solutions.
November: AAO 2017 issue
IOLs Around the World: While the long-awaited Symfony lens received FDA approval last summer, other lenses that are being used abroad are still out of reach for U.S. ophthalmologists. Which of these will be gamechangers?
Distributed at AAO 2017
Ophthalmic Pathology Refresher: What do you remember from your ophthalmic pathology rotation? We thought so. Here are the top 5 things you need to brush up on, as well as tips for talking to a pathologist.